- Home
- GNW vs LIVN Comparison
GNW vs LIVN Comparison
Compare GNW & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GNW | LIVN |
|---|---|---|
| Founded | 1871 | 1987 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Life Insurance | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.5B |
| IPO Year | 2004 | 2015 |
Fundamental Metrics
Financial Performance| Metric | GNW | LIVN |
|---|---|---|
| Price | $9.16 | $81.88 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 7 |
| Target Price | $10.50 | ★ $72.43 |
| AVG Volume (30 Days) | ★ 3.2M | 730.1K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.12 | ★ 0.40 |
| Revenue | ★ $7,301,000,000.00 | N/A |
| Revenue This Year | N/A | $9.79 |
| Revenue Next Year | N/A | $6.63 |
| P/E Ratio | ★ $76.83 | $206.30 |
| Revenue Growth | ★ 0.08 | N/A |
| 52 Week Low | $7.13 | $41.02 |
| 52 Week High | $9.69 | $85.27 |
Technical Indicators
Market Signals| Indicator | GNW | LIVN |
|---|---|---|
| Relative Strength Index (RSI) | 48.10 | 62.21 |
| Support Level | $7.97 | $61.63 |
| Resistance Level | $9.22 | N/A |
| Average True Range (ATR) | 0.17 | 2.07 |
| MACD | -0.03 | -0.28 |
| Stochastic Oscillator | 26.00 | 59.16 |
Price Performance
Historical ComparisonAbout GNW Genworth Financial Inc
Genworth Financial Inc is a diversified insurance holding company that provides various mortgage and life insurance products. The company has four main operating business segments: Enact, Closed Block segment, and Corporate and Other. The company's product portfolio includes various financial products such as traditional life insurance, mortgage insurance, fixed annuities, and variable annuities. The majority of the revenue is generated by the Enact segment. The company earns the maximum of its revenue in the United States.
About LIVN LivaNova PLC
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.